Sae Hyung Lee

Title: Innovations of Sae Hyung Lee

Introduction

Sae Hyung Lee is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic proteins. His work focuses on innovations that have the potential to impact medical treatments.

Latest Patents

One of Sae Hyung Lee's key patents is related to a type 1 interferon neutralizing FC-fusion protein. This invention involves a dimer-type polypeptide that includes a monomer comprising an interferon receptor fragment or an antibody Fc fragment. The patent outlines a preparation method for this protein and a pharmaceutical composition that includes it. The type 1 interferon neutralizing FC-fusion protein effectively blocks the binding between type 1 interferon and its receptor. This innovation demonstrates an excellent ability to inhibit the signaling and biological activities of interferon, which can lead to effective treatments for diseases mediated by type 1 interferon.

Career Highlights

Sae Hyung Lee has worked with prestigious institutions, including Seoul National University and the Logone Bio Convergence Research Foundation. His experience in these organizations has allowed him to advance his research and contribute to significant scientific developments.

Collaborations

Sae Hyung Lee has collaborated with notable colleagues, including Young Kee Shin and Sung Su Kim. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Sae Hyung Lee's contributions to biotechnology, particularly through his patent on type 1 interferon neutralizing FC-fusion protein, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.